These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39142759)

  • 1. In-Stent Restenosis: Is the Future Bioresorbable?
    Claessen BE; Feldman DN
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1837-1839. PubMed ID: 39142759
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-Term Results of Bioresorbable Vascular Scaffolds in Patients With In-Stent Restenosis: The RIBS VI Study.
    Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Bosa F; Pérez de Prado A; Rumoroso JR; Romaguera R; Gutiérrez H; García Touchard A; López-Mínguez JR; Trillo R; de la Torre Hernández JM; Moreno R; Velázquez M; Moris C; Kockar MJ; Jiménez-Quevedo P; Bastante T; Val DD; Rivero F; Alfonso F
    JACC Cardiovasc Interv; 2024 Aug; 17(15):1825-1836. PubMed ID: 39142758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
    Moscarella E; Ielasi A; Granata F; Coscarelli S; Stabile E; Latib A; Cortese B; Tespili M; Tanaka A; Capozzolo C; Caliendo L; Colombo A; Varricchio A
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003148. PubMed ID: 27059683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 6. A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.
    Versaci F; Vizzari G; Prati F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2020 May; 21(5):398-400. PubMed ID: 32243342
    [No Abstract]   [Full Text] [Related]  

  • 7. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of In-Stent Restenosis: When the Stent Is No Longer There.
    Antuña P; Cuesta J; García-Guimaraes M; Bastante T; De Rueda C; Rivero F; Alfonso F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):e53-e55. PubMed ID: 31883713
    [No Abstract]   [Full Text] [Related]  

  • 9. New-Generation Drug-Eluting Stents for Left Main In-Stent Restenosis: The DELTA-2 Registry.
    Giustino G; Tanaka A; Erglis A; Morice MC; Van Mieghem NM; Meliga E; D'Ascenzo F; Stefanini GG; Capodanno D; Chieffo A;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2438-2440. PubMed ID: 30522680
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioresorbable scaffolds for the treatment of in-stent restenosis.
    Dörr O; Liebetrau C; Wiebe J; Hecker F; Rixe J; Möllmann H; Hamm C; Nef H
    Heart Vessels; 2015 Mar; 30(2):265-9. PubMed ID: 24390727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable Vascular Scaffolds for Patients With In-Stent Restenosis: The RIBS VI Study.
    Alfonso F; Cuesta J; Pérez-Vizcayno MJ; García Del Blanco B; Rumoroso JR; Bosa F; Pérez de Prado A; Masotti M; Moreno R; Cequier A; Gutiérrez H; García Touchard A; López-Mínguez JR; Zueco J; Martí V; Velázquez M; Morís C; Bastante T; García-Guimaraes M; Rivero F; Fernández C;
    JACC Cardiovasc Interv; 2017 Sep; 10(18):1841-1851. PubMed ID: 28866036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
    Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
    Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment of In-Stent Restenosis.
    Bastante T; Rivero F; Benedicto A; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1264-1265. PubMed ID: 26292592
    [No Abstract]   [Full Text] [Related]  

  • 15. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
    Granata F; Moscarella E; Varricchio A
    Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
    [No Abstract]   [Full Text] [Related]  

  • 16. Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.
    Rivero F; Benedicto A; Bastante T; Cuesta J; Diego G; Alfonso F
    EuroIntervention; 2015 Nov; 11(7):780. PubMed ID: 25308302
    [No Abstract]   [Full Text] [Related]  

  • 17. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study).
    Moscarella E; Tanaka A; Ielasi A; Cortese B; Coscarelli S; De Angelis MC; Piraino D; Latib A; Grigis G; Bianchi R; Buccheri D; Calabrò P; Tespili M; Silva Orrego P; Colombo A; Varricchio A
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):668-677. PubMed ID: 29356269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.
    Pleva L; Kukla P; Kusnierova P; Zapletalova J; Hlinomaz O
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003316. PubMed ID: 27069104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illustration of the Resorption Process Between 2 Different Overlapping Bioresorbable Scaffolds.
    Tanaka A; Jabbour RJ; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1469-1470. PubMed ID: 27085427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.